[Urgent] Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

Brian T. Griffin net worth and biography

Brian Griffin Biography and Net Worth

CEO of Elevance Health

Brian T. Griffin serves as Independent Director of the Company. Mr. Griffin has a proven track record of over 35 years of senior leadership and operational experience in healthcare. He most recently served as Chairman and Chief Executive Officer of Diplomat Pharmacy Inc., one of the nation's largest independent Specialty Pharmacies and Pharmacy Benefit Managers (PBM), until it was recently acquired by UnitedHealth Group Inc. (NYSE: UNH). Previously, Mr. Griffin joined Anthem (NYSE: ANTM), in 2013, initially as President and Chief Executive Officer of its Empire BlueCross BlueShield - New York Company, and ultimately assuming the role of President of Anthem's Commercial Business, including its 14 BlueCross BlueShield plans nationwide. Thereafter, Mr. Griffin was named Chief Executive Officer of IngenioRx, Anthem's wholly owned national PBM. Mr. Griffin also held positions of increasing responsibility with Medco Health Solutions, Inc. and US Healthcare, Inc.

What is Brian T. Griffin's net worth?: The estimated net worth of Brian T. Griffin is at least $10.27 million as of May 3rd, 2018. Mr. Griffin owns 25,619 shares of Elevance Health stock worth more than $10,267,455 as of November 15th. This net worth evaluation does not reflect any other investments that Mr. Griffin may own. Learn More about Brian T. Griffin's net worth.
How do I contact Brian T. Griffin?: The corporate mailing address for Mr. Griffin and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Brian T. Griffin's contact information.
Has Brian T. Griffin been buying or selling shares of Elevance Health?: Brian T. Griffin has not been actively trading shares of Elevance Health during the past quarter. Most recently, Brian T. Griffin sold 59,421 shares of the business's stock in a transaction on Thursday, May 3rd. The shares were sold at an average price of $224.41, for a transaction totalling $13,334,666.61. Following the completion of the sale, the chief executive officer now directly owns 25,619 shares of the company's stock, valued at $5,749,159.79. Learn More on Brian T. Griffin's trading history.
Who are Elevance Health's active insiders?: Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.
Are insiders buying or selling shares of Elevance Health?: In the last year, insiders at the sold shares 6 times. They sold a total of 57,339 shares worth more than $28,701,403.88. The most recent insider tranaction occured on October, 18th when EVP Charles Morgan Kendrick Jr sold 7,417 shares worth more than $3,205,182.38. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.
Information on this page was last updated on 10/18/2024.

Brian T. Griffin Insider Trading History at Elevance Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/3/2018	Sell	59,421	$224.41	$13,334,666.61	25,619

Brian T. Griffin Buying and Selling Activity at Elevance Health

Elevance Health Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $400.78

$398.43

$408.58

50 Day Range

MA: $478.13

$405.83

$553.50

2 Week Range

Now: $400.78

$397.98

$567.26

Volume

2,616,529 shs

Average Volume

1,164,884 shs

Market Capitalization

$92.95 billion

P/E Ratio

14.61

Dividend Yield

1.59%

Beta

0.85